DK0895478T3 - Bestanddel B som ardanner - Google Patents

Bestanddel B som ardanner

Info

Publication number
DK0895478T3
DK0895478T3 DK96914107T DK96914107T DK0895478T3 DK 0895478 T3 DK0895478 T3 DK 0895478T3 DK 96914107 T DK96914107 T DK 96914107T DK 96914107 T DK96914107 T DK 96914107T DK 0895478 T3 DK0895478 T3 DK 0895478T3
Authority
DK
Denmark
Prior art keywords
pct
component
scarring
sec
date
Prior art date
Application number
DK96914107T
Other languages
English (en)
Inventor
Francesco Borrelli
Silvia Donini
Fabrizio Martelli
Renato Mastrangeli
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of DK0895478T3 publication Critical patent/DK0895478T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dental Preparations (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • External Artificial Organs (AREA)
  • Glass Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
DK96914107T 1996-04-24 1996-04-24 Bestanddel B som ardanner DK0895478T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002251356A CA2251356A1 (en) 1996-04-24 1996-04-24 Component b as cicatrizant
PCT/EP1996/001702 WO1997039765A1 (en) 1996-04-24 1996-04-24 Component b as cicatrizant

Publications (1)

Publication Number Publication Date
DK0895478T3 true DK0895478T3 (da) 2003-06-23

Family

ID=25680594

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96914107T DK0895478T3 (da) 1996-04-24 1996-04-24 Bestanddel B som ardanner

Country Status (14)

Country Link
US (1) US5998364A (da)
EP (1) EP0895478B1 (da)
JP (1) JP3882943B2 (da)
AT (1) ATE234110T1 (da)
AU (1) AU727618B2 (da)
CA (1) CA2251356A1 (da)
DE (1) DE69626691T2 (da)
DK (1) DK0895478T3 (da)
EA (1) EA001077B1 (da)
ES (1) ES2188754T3 (da)
IL (1) IL120696A (da)
NO (1) NO320611B1 (da)
WO (1) WO1997039765A1 (da)
ZA (1) ZA973442B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002520292A (ja) * 1998-07-09 2002-07-09 アプライド・リサーチ・システムズ・エイアールエス・ホールディング・ナムローゼ・フェンノートシャップ ヒト成長因子と組み合わせた血管形成剤としてのコンパウンドｂの使用
ES2359408T3 (es) * 2003-04-16 2011-05-23 Merck Serono Sa Uso de slurp-1 para tratar enfermedades relacionadas con la disfunción de receptores de acetilcolina.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE53166B1 (en) * 1980-08-05 1988-08-03 Searle & Co Synthetic urogastrone gene,corresponding plasmid recombinants,transformed cells,production thereof and urogastrone expression
IT1257184B (it) * 1992-12-22 1996-01-10 Applied Research Systems Preparato ad attivita' antinfiammatoria, anticoagulante e antitumorale

Also Published As

Publication number Publication date
WO1997039765A1 (en) 1997-10-30
ES2188754T3 (es) 2003-07-01
NO984965D0 (no) 1998-10-23
ATE234110T1 (de) 2003-03-15
DE69626691D1 (de) 2003-04-17
DE69626691T2 (de) 2003-08-14
CA2251356A1 (en) 1997-10-30
JP2000510436A (ja) 2000-08-15
NO320611B1 (no) 2005-12-27
EA001077B1 (ru) 2000-10-30
ZA973442B (en) 1998-02-23
NO984965L (no) 1998-12-01
AU5760596A (en) 1997-11-12
EP0895478A1 (en) 1999-02-10
EA199800953A1 (ru) 1999-04-29
JP3882943B2 (ja) 2007-02-21
EP0895478B1 (en) 2003-03-12
IL120696A (en) 2001-10-31
IL120696A0 (en) 1997-08-14
US5998364A (en) 1999-12-07
AU727618B2 (en) 2000-12-14

Similar Documents

Publication Publication Date Title
NO307027B1 (no) Anvendelse av riluzol ved behandling av neurologiske lesjoner relatert til traumatiske skader
TR200102308T2 (tr) Yüzey etkinliğine sahip yapay peptidler ve bunların yapay yüzey aktif maddelerin hazırlanmasında kullanımı
EE9900118A (et) H+,K+-ATPaasi inhibiitorite kasutamine ninapolüüpide ravimisel
GB9320820D0 (en) Compounds for medicinal use
DK0895478T3 (da) Bestanddel B som ardanner
AU6624996A (en) Use of betaglycan to reduce scarring
GB9626472D0 (en) New use of comt inhibitors
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
IS5231A (is) Vefjaþáttur sem hefur áhrif á blóðæðarmyndun
WO1998030212A3 (de) Verwendung von aminothiazolen zur verbesserung der wundheilung
MD980129A (en) Antiherpetic remedy
SE9403861D0 (sv) Novel medicinal use
GB9723824D0 (en) Cytostatic agents
UA32315A (uk) Спосіб накладання шкірного шва
UA32281A (uk) Засіб "регенерин" для зовнішнього лікування гнійних ран і трофічних виразок